The Jerome Lejeune Foundation is the world’s oldest and largest funder of research into treatments for intellectual disabilities of genetic origin, especially, but not limited to, Down syndrome. The Foundation’s specific research interest is to discover a means to prevent and/or treat genetic intellectual disabilities in order to improve the memory, speech, and cognition of patients.

Applicants: Researchers who are developing research projects aiming at identification of treatments to improve the cognitive deficits of patients, especially those with trisomy 21 (Down syndrome) and other rare abnormalities such as fragile X, cri du chat, Rett, Williams-Beuren, Prader-Willi, Angelman, and other syndromes, excluding autism.

In the current call for grants, the Jerome Lejeune Foundation will provide a special consideration to projects leading to a better understanding of the mechanisms of accelerated brain aging associated with trisomy 21.

Amount and duration: Grants are offered for 1 or 2 years and funding is variable in the range of 20,000 € per year. Clinical projects could benefit from more funding. The Jerome Lejeune Foundation also funds the organization of conferences or courses.

Deadline:

- Internal VHIR deadline for proposals: August 11, 2014

- Official deadline: August 19, 2014

Further information: HERE

Acess to on-line application system: HERE